Diabetes, Vol 39, Issue 3 383-389, Copyright © 1990 by American Diabetes Association

ARTICLES

Operation of Randle's cycle in patients with NIDDM

S Bevilacqua, G Buzzigoli, R Bonadonna, LS Brandi, M Oleggini, C Boni, M Geloni and E Ferrannini
Metabolism Unit, Consiglio Nazionale delle Ricerche, Pisa, Italy.

It has been suggested that the insulin resistance of non-insulin-dependent diabetes mellitus (NIDDM) may be caused by substrate competition between glucose and free fatty acids (FFAs) (Randle's cycle). We measured substrate oxidation and energy metabolism in 10 nonobese untreated NIDDM patients with fasting glucose levels of 7-8 mM with indirect calorimetry in the basal state and during an isoglycemic-hyperinsulinemic (approximately 100 mU/L) clamp without (control) and with a concomitant infusion (approximately 0.35 mmol/min) of Intralipid, a triglyceride emulsion. In the control study, fasting rates of total glucose turnover [( 3-3H]glucose) and glucose and lipid oxidation (9.4 +/- 1.4, 7.3 +/- 1.3, and 3.0 +/- 0.4 mumol.kg-1.min-1, respectively) were comparable with those of nondiabetic individuals. After insulin administration, lipid oxidation was normally suppressed (to 1.3 +/- 0.3 mumol.kg-1.min-1, P less than 0.01), as were the circulating levels of FFA, glycerol, and beta-hydroxybutyrate, whereas glucose oxidation doubled (14.1 +/- 1.8 mumol.kg-1.min-1, P less than 0.01). Because glycemia was clamped at 7.5 mM, endogenous glucose production (EGP) was completely suppressed, and total glucose disposal was stimulated (to 25.7 +/- 5.2 mumol.kg-1.min-1, P less than 0.01 vs. baseline), but glucose clearance (3.6 +/- 0.8 ml.kg-1.min-1) was 30% reduced compared with normal. With concomitant lipid infusion, FFA, glycerol, and beta-hydroxybutyrate all rose during the clamp; correspondingly, lipid oxidation was maintained at fasting rates (3.6 +/- 0.2 mumol.kg-1.min-1, P less than 0.01 vs. control).(ABSTRACT TRUNCATED AT 250 WORDS)
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. Kudo, J. Wu, Y. Ogawa, S. Suga, N. Hasegawa, T. Suda, H. Mizukami, S. Yagihashi, and M. Wakui Novel Mechanism of Chronic Exposure of Oleic Acid-Induced Insulin Release Impairment in Rat Pancreatic beta-Cells J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1203 - 1210. [Abstract] [Full Text] [PDF]

				O. Wuesten, C. H. Balz, R. G. Bretzel, H.-U. Kloer, and P. D. Hardt Effects of Oral Fat Load on Insulin Output and Glucose Tolerance in Healthy Control Subjects and Obese Patients Without Diabetes Diabetes Care, February 1, 2005; 28(2): 360 - 365. [Abstract] [Full Text] [PDF]

				S. R. Kashyap, R. Belfort, R. Berria, S. Suraamornkul, T. Pratipranawatr, J. Finlayson, A. Barrentine, M. Bajaj, L. Mandarino, R. DeFronzo, et al. Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes Am J Physiol Endocrinol Metab, September 1, 2004; 287(3): E537 - E546. [Abstract] [Full Text] [PDF]

				H. Storgaard, C. B. Jensen, M. Bjornholm, X. M. Song, S. Madsbad, J. R. Zierath, and A. A. Vaag Dissociation between Fat-Induced in Vivo Insulin Resistance and Proximal Insulin Signaling in Skeletal Muscle in Men at Risk for Type 2 Diabetes J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1301 - 1311. [Abstract] [Full Text] [PDF]

				M. K. S. Leow, C. L. Addy, and C. S. Mantzoros Human Immunodeficiency Virus/Highly Active Antiretroviral Therapy-Associated Metabolic Syndrome: Clinical Presentation, Pathophysiology, and Therapeutic Strategies J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 1961 - 1976. [Full Text] [PDF]

				G. Boden, P. Cheung, T. P. Stein, K. Kresge, and M. Mozzoli FFA cause hepatic insulin resistance by inhibiting insulin suppression of glycogenolysis Am J Physiol Endocrinol Metab, July 1, 2002; 283(1): E12 - E19. [Abstract] [Full Text] [PDF]

				P. G. McTernan, A. L. Harte, L. A. Anderson, A. Green, S. A. Smith, J. C. Holder, A. H. Barnett, M. C. Eggo, and S. Kumar Insulin and Rosiglitazone Regulation of Lipolysis and Lipogenesis in Human Adipose Tissue In Vitro Diabetes, May 1, 2002; 51(5): 1493 - 1498. [Abstract] [Full Text] [PDF]

				G. F. Lewis, A. Carpentier, K. Adeli, and A. Giacca Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes Endocr. Rev., April 1, 2002; 23(2): 201 - 229. [Abstract] [Full Text] [PDF]

				L. H. Clerk, S. Rattigan, and M. G. Clark Lipid Infusion Impairs Physiologic Insulin-Mediated Capillary Recruitment and Muscle Glucose Uptake In Vivo Diabetes, April 1, 2002; 51(4): 1138 - 1145. [Abstract] [Full Text] [PDF]

				J. M. Abadie, G. T. Malcom, J. R. Porter, and F. Svec Dehydroepiandrosterone Alters Zucker Rat Soleus and Cardiac Muscle Lipid Profiles Experimental Biology and Medicine, September 1, 2001; 226(8): 782 - 789. [Abstract] [Full Text] [PDF]

				F. G. Hamel, R. G. Bennett, J. L. Upward, and W. C. Duckworth Insulin Inhibits Peroxisomal Fatty Acid Oxidation in Isolated Rat Hepatocytes Endocrinology, June 1, 2001; 142(6): 2702 - 2706. [Abstract] [Full Text] [PDF]

				S. Vigili de Kreutzenberg, C. Crepaldi, S. Marchetto, L. Calò, A. Tiengo, S. Del Prato, and A. Avogaro Plasma Free Fatty Acids and Endothelium-Dependent Vasodilation: Effect of Chain-Length and Cyclooxygenase Inhibition J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 793 - 798. [Abstract] [Full Text]

				M. L. Evans, K. Matyka, J. Lomas, A. Pernet, I. C. P. Cranston, I. Macdonald, and S. A. Amiel Reduced Counterregulation during Hypoglycemia with Raised Circulating Nonglucose Lipid Substrates: Evidence for Regional Differences in Metabolic Capacity in the Human Brain? J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2952 - 2959. [Abstract] [Full Text]

				B. M. Jucker, A. J.M. Rennings, G. W. Cline, and G. I. Shulman 13C and 31P NMR Studies on the Effects of Increased Plasma Free Fatty Acids on Intramuscular Glucose Metabolism in the Awake Rat J. Biol. Chem., April 18, 1997; 272(16): 10464 - 10473. [Abstract] [Full Text] [PDF]